Buprenorphine vs Rituximab

Buprenorphine vs Rituximab: Overview

This comparison examines the pharmacological differences between Buprenorphine and Rituximab.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Buprenorphine — 24-42 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Buprenorphine — C29H41NO4.

Molecular Weight: Buprenorphine — 467.6430 g/mol.

Type: Buprenorphine — Small molecule; Rituximab — Antibody.